Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2411876Generated: November 1, 2026

(4-Bromo-2-methylphenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone → 1-{4-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-methylphenyl}-5-methylimidazolidine-2,4-dione

https://huagongshe.com/reaction/2411876

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(4-Bromo-2-methylphenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanoneHCID 58484835—
Reactant3-(4-Methoxybenzyl)-5-methylimidazolidine-2,4-dioneHCID 68328356—
Reactant1-{4-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-methylphenyl}-3-(4-methoxybenzyl)-5-methylimidazolidine-2,4-dioneHCID 71252577—
Product1-{4-[4-(3,5-Dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-methylphenyl}-5-methylimidazolidine-2,4-dioneHCID 71251933—

Reaction Steps

Using (4-bromo-2-methylphenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (311 mg) described in Preparation Example 118 and 3-(4-methoxybenzyl)-5-methylimidazolidine-2,4-dione (225 mg) described in Preparation Example 51 and by the reaction and treatment in the same manner as in Example 508, the title compound (91 mg) was obtained via 1-{4-[4-(3,5-dimethylpyridin-2-yl)piperazine-1-carbonyl]-3-methylphenyl}-3-(4-methoxybenzyl)-5-methylimidazolidine-2,4-dione.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08816079B2
Source datasetuspto-grants-2014_08
ORD IDord-36a397a42e9a4e96b82b22cd954da0fa
Source noteuspto-grants-2014_08